Lead Drug Discovery

The method by which a drug is delivered can have a significant effect on its efficacy. To minimize drug degradation and loss, to prevent harmful side-effects and to increase drug bioavailability and the fraction of the drug accumulated in the required zone, various drug delivery and drug targeting systems are currently under development. Attempts are being made to develop therapeutic proteins for cancer, hepatitis, and autoimmune conditions, but their clinical applications are limited, except in the cases of drugs based on erythropoietin, granulocyte colony-stimulating factor, interferon-alpha, and antibodies, owing to problems with fundamental technologies for protein drug discovery. Technologies profiled include those used for biomarker and target discovery such as high throughput screening, signal transduction, micro array, RNAi, metabolomics, toxicogenomics, biosensors and nanotechnology.

  • Choosing Disease and Drug Target
  • Identification of Pharmacophore
  • Lead Compounds and SAR
  • High throughput screening
  • Computer-aided drug design

Related Conference of Lead Drug Discovery

April 26-27, 2021

11th World Congress on Chromatography

Amsterdam, Netherlands
April 26-27, 2021

4th International Conference on Chemistry Education and Research

Singapore City, Singapore
April 28-29, 2021

12th World Congress on Chemistry

London, UK
May 24-25, 2021

10th Global Summit on Mass Spectrometry

Amsterdam, Netherlands
June 21-22, 2021

11th European Chemistry Congress

Barcelona, Spain
July 07-08, 2021

10th World Congress on Mass Spectrometry

Valencia, Spain
July 26-27, 2021

17th European Organic Chemistry Congress

London, UK
September 28-29, 2021

2 nd World Congress on Polymer Materials

Auckland, Newzealand
December 07-08, 2021

Global Meet on Green and Sustainable Chemistry

Sydney, Australia

Lead Drug Discovery Conference Speakers

Recommended Sessions

Related Journals

Are you interested in